![](https://investorshub.advfn.com/uicon/65335.png?cb=1484493325)
Tuesday, July 12, 2022 3:03:58 PM
CUBT: Metformin eye drops instead of a needle+Big Pharma+$B MC.
conix
Friday, July 01, 2022 8:34:34 AM
Re: iRobot post# 38778
Post#
38781
of 38786
The question is not what the price per share would be if Metformin eye drop formulation was proven effective and eventually sold to a Big Pharma. A number of steps will happen before that -- like an announced partnership with investment into the company--that will have an effect on the market capitalization of the company.
An effective therapy for AMD through direct delivery to the eye with no need of injections into the eye would be worth well over $2 Billion, imo. Depending upon how many shares there are outstanding at the time--regardless of a RS or not--it would be substantially higher than the current market cap even accounting for a capital raise.
In a perfect world, the company would be flush with cash and already on NASDAQ. Judging by the filings and charts, three years ago, this ticker symbol was worth basically nothing with no business plan or future.
Recent CUBT News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 05/06/2024 09:31:41 PM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM